| Application no. and date | 08151945.6 (espacenet) (Federated) (European Patent Register), 20000615 | | Patent/reg. no. and date | DK/EP 1977751, 20130724 | | Publication date | 20081008 | | Priority no. and date | JP 17150999, 19990617 | | EP pub. no. and date |
EP 1977751 20081008 | | Effective date | | | Applicant/owner | Takeda Pharmaceutical Company Limited, 1-1, Doshomachi 4-chome
Chuo-ku
Osaka-shi
Osaka, JP | | Applicant ref. no. | 157539 | | Inventor | Fujishima, Akira, 1-6, Fujigaoka 1-chome,
Sanda-shi
Hyogo Osaka 669-1547, JP,
Aoki, Isao, 17-1 Daiwahigashi 3-chome,
Kawanishi-shi
Hyogo 666-0111, JP,
Kamiyama, Keiji, c/o Takeda Pharmaceutical Company Limited,
10 Wadai
Tsukuba-shi,
Ibaraki 300-4293, JP | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/44 (2006.01) , A61K 31/4439 (2006.01) , C07D 401/12 (2006.01) , A61P 1/04 (2006.01) | | Title | Amorf (R)-2-[[[3-methyl-4-(2,2,2-trifluorethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazol som middel mod ulcus | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
